A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
Clinical trial NCT06378697 · COMPLETED
Trial details
- NCT number
- NCT06378697
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2025-02-19
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.